![]() |
市場調查報告書
商品編碼
1396564
血液處理和儲存設備市場規模- 按產品(設備(血漿冷凍機、血細胞比容離心機、加溫器)、消耗品(採血針、過濾器、給藥裝置))、最終用途- 全球預測,2023 -2032 年Blood Processing and Storage Equipment Market Size - By Product (Device (Plasma Freezer, Hematocrit Centrifuge, Warmer) Consumable (Blood Lancet, Filter, Administration Set)), End-use - Global Forecast, 2023-2032 |
由於全球血液疾病的盛行率不斷增加,血液處理和儲存設備市場規模從 2023 年到 2032 年的CAGR預計將達到 7.1%。貧血、血友病和白血病等疾病需要先進的血液處理和儲存解決方案來進行診斷、治療和治療干預。這些疾病的發生率不斷上升,加上人口老化,進一步推動了醫療機構對高效、可靠設備的需求。
隨著醫學研究活動的不斷發展,產業參與者正在開發新的療法和治療方法,以滿足對複雜血液處理和儲存技術不斷成長的需求,從而增強了產業前景。例如,Terumo Blood and Cell Technologies 的 Reveos 自動化全血處理系統於 2023 年 8 月獲得美國 FDA 批准,該系統可協助在單一離心循環中將血液處理成血小板和各種成分。
血液處理和儲存設備市場分為產品、最終用途和區域。
從產品來看,包括採血針、過濾器和注射器在內的消耗品領域的市場佔有率預計從 2023 年到 2032 年將達到 7.3% 的CAGR。人口迅速老化、輸血意識不斷提高以及醫療程序的進步,對高效血液處理和儲存的需求激增。此外,材料和技術不斷創新,以確保提高血液管理的安全性和有效性,可能會推動該領域的成長。
就最終用途而言,醫院和診所領域的血液處理和儲存設備行業在2022 年產生了可觀的收入,預計到2032 年將實現6.9% 的成長率。醫院和診所嚴重依賴高效的血液管理系統來確保患者安全並簡化醫療程序。此外,醫療機構對血液相關治療、手術和緊急護理的需求不斷成長,正在促進先進處理和儲存設備的採用。
由於醫療基礎設施的持續發展、血液安全意識的提高以及人口的成長,到 2032 年,亞太地區血液處理和儲存設備行業的CAGR將達到 7.8%。此外,醫療技術的進步和血液相關治療需求的不斷成長正在推動複雜的處理和儲存設備的採用。此外,由於人們對公共衛生的日益關注,亞太地區多個政府正在投資醫療基礎設施,以增強血庫和醫療設施的能力,進一步推動區域產業擴張。
Blood Processing and Storage Equipment Market size is poised to expand at 7.1% CAGR from 2023-2032 owing to the increasing prevalence of blood disorders globally. Conditions, such as anemia, hemophilia, and leukemia are necessitating advanced blood processing and storage solutions for diagnosis, treatment, and therapeutic interventions. The rising incidence of these disorders coupled with the growing aging population is further driving the demand for efficient and reliable equipment in healthcare facilities.
With the advancing medical research activities, industry participants are developing new therapies and treatments to address the escalating requirement for sophisticated blood processing and storage technologies, augmenting the industry outlook. For instance, Terumo Blood and Cell Technologies, in August 2023, received the U.S. FDA approval for the Reveos Automated Whole Blood Processing System to help process blood into platelets and various components in a single centrifugation cycle.
The blood processing and storage equipment market is segmented into product, end-use, and region.
Based on product, the market share from the consumables segment, comprising blood lancet, filter, and administration, is estimated to record 7.3% CAGR from 2023-2032. The rapidly aging population, the rising awareness about blood transfusions and higher advances in medical procedures is surging the demand for efficient blood processing and storage. Additionally, the rising innovations in materials and technologies to ensure enhanced safety and efficacy in blood management are likely to propel the segment growth.
In terms of end-use, the blood processing and storage equipment industry from the hospitals and clinics segment generated substantial revenue in 2022 and is estimated to witness 6.9% growth rate through 2032. Hospitals and clinics rely heavily on efficient blood management systems to ensure patient safety and streamline the medical procedures. Furthermore, the increasing demand for blood-related treatments, surgeries, and emergency care in healthcare facilities is promoting the adoption of advanced processing and storage equipment.
Asia Pacific blood processing and storage equipment industry is set to exhibit a 7.8% CAGR through 2032 owing to the ongoing healthcare infrastructure development, rising awareness about blood safety, and the growing population. Moreover, advancements in medical technology and the rising need for blood-related treatments are fueling the adoption of sophisticated processing and storage equipment. Furthermore, several governments across the Asia Pacific are investing in healthcare infrastructure for enhancing the capabilities of blood banks and medical facilities attributed to the rising focus on public health, further boosting the regional industry expansion.